Gene · 10249
Papers1,688
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,688
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Two multidrug-resistant Proteus mirabilis clones carrying extended spectrum beta-lactamases revealed in a single hospital department by whole genome sequencing. | Heliyon | 2024 | 39687096 | PubTator, text mining | PubMed |
| Data-Driven Approaches in Antimicrobial Resistance: Machine Learning Solutions. | Antibiotics (Basel) | 2024 | 39596745 | PubTator, text mining | PubMed |
| TPGPred: A Mixed-Feature-Driven Approach for Identifying Thermophilic Proteins Based on GradientBoosting. | Int J Mol Sci | 2024 | 39595936 | PubTator, text mining | PubMed |
| Identification and characterisation of colistin-resistant Acinetobacter colistiniresistens co-producing IMP-1 and OXA-58 carbapenemases. | New Microbes New Infect | 2024 | 39559178 | PubTator, text mining | PubMed |
| B cell epitope prediction by capturing spatial clustering property of the epitopes using graph attention network. | Sci Rep | 2024 | 39528630 | PubTator, text mining | PubMed |
| Molecular Characterization of Pseudomonas aeruginosa Clinical Isolates Through Whole-Genome Sequencing: A Comprehensive Analysis of Biotypes, Sequence Types, and Antimicrobial and Virulence Genes. | Cureus | 2024 | 39525128 | PubTator, text mining | PubMed |
| Downregulation of GLYAT correlates with tumour progression and poor prognosis in hepatocellular carcinoma. | J Cell Mol Med | 2024 | 39495775 | PubTator, text mining | PubMed |
| GLYAT suppresses liver cancer and clear cell renal cell carcinoma progression by downregulating ROCK1 expression. | Transl Cancer Res | 2024 | 39430840 | PubTator, text mining | PubMed |
| Distribution characteristics of integrons and correlation analysis of antibiotic resistance in urine isolated Enterobacter cloacae. | Front Cell Infect Microbiol | 2024 | 39411318 | PubTator, text mining | PubMed |
| SPOT: A machine learning model that predicts specific substrates for transport proteins. | PLoS Biol | 2024 | 39325691 | PubTator, text mining | PubMed |
| Prevalence and molecular characterization of multidrug-resistant coagulase negative staphylococci from urban wastewater in Delhi-NCR, India. | Arch Microbiol | 2024 | 39254720 | PubTator, text mining | PubMed |
| Problematic internet use: A growing concern for adolescent health and well-being in a digital era. | J Glob Health | 2024 | 39212531 | PubTator, text mining | PubMed |
| Ways of modulating GABA transporters to treat neurological disease. | Expert Opin Ther Targets | 2024 | 39068514 | PubTator, text mining | PubMed |
| Towards interpretable Cryo-EM: disentangling latent spaces of molecular conformations. | Front Mol Biosci | 2024 | 39044842 | PubTator, text mining | PubMed |
| Whole-Genome Analysis of Extensively Drug-Resistant Enterobacter hormaechei Isolated from a Patient with Non-Hodgkin's Lymphoma. | Genes (Basel) | 2024 | 38927749 | PubTator, text mining | PubMed |
| Environmental microbiome diversity and stability is a barrier to antimicrobial resistance gene accumulation. | Commun Biol | 2024 | 38851788 | PubTator, text mining | PubMed |
| BioPrediction-RPI: Democratizing the prediction of interaction between non-coding RNA and protein with end-to-end machine learning. | Comput Struct Biotechnol J | 2024 | 38827228 | PubTator, text mining | PubMed |
| Identification of a novel Providencia species showing multi-drug-resistant in three patients with hospital-acquired infection. | Int J Antimicrob Agents | 2024 | 38795927 | PubTator, text mining | PubMed |
| Correction: Highly accurate prediction of flammability limits of chemical compounds using novel integrated hybrid models. | PLoS One | 2024 | 38748702 | PubTator, text mining | PubMed |
| The emerging roles of glutamine amidotransferases in metabolism and immune defense. | Nucleosides Nucleotides Nucleic Acids | 2024 | 38743960 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10249/papers?page=6